Drug Companies Step Forward with Voluntary Price Caps on Inhalers
Sunday, June 16th, 2024
Drug companies Boehringer Ingelheim, AstraZeneca and GSK are capping out-of-pocket costs for their asthma inhalers at $35 per month for eligible patients.
The price caps for Boehringer Ingelheim and AstraZeneca inhaler products went into effect on June 1, 2024. GSK says it will implement a similar $35 price cap no later than January 1, 2025. […]
Click to Read More: Drug Companies Step Forward with Voluntary Price Caps on Inhalers
